In this article, Sino Biological discusses the evolution of antibody humanization and affinity maturation and how this affects the life sciences field.
Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections worldwide, recently there has been a surge in interest in RSV antigens, antibodies, and more in therapeutic and immunological development.